OPENLANE (NYSE:KAR – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at Barrington Research in a research report issued on Friday, Benzinga reports. They currently have a $25.00 price objective on the specialty retailer’s stock. Barrington Research’s price target indicates a potential upside of 49.25% from the company’s current price.
OPENLANE Price Performance
KAR stock traded down $0.17 on Friday, reaching $16.75. The company’s stock had a trading volume of 356,311 shares, compared to its average volume of 722,093. OPENLANE has a 52 week low of $12.86 and a 52 week high of $18.73. The company has a market capitalization of $1.81 billion, a P/E ratio of -9.36, a price-to-earnings-growth ratio of 1.65 and a beta of 1.44. The firm has a fifty day moving average of $17.25 and a two-hundred day moving average of $17.05.
OPENLANE (NYSE:KAR – Get Free Report) last released its quarterly earnings results on Wednesday, August 7th. The specialty retailer reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.02). OPENLANE had a return on equity of 7.85% and a net margin of 3.39%. The business had revenue of $431.80 million during the quarter, compared to the consensus estimate of $426.11 million. During the same period in the previous year, the company posted $0.25 EPS. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. As a group, equities analysts expect that OPENLANE will post 0.78 EPS for the current fiscal year.
Institutional Inflows and Outflows
OPENLANE Company Profile
OPENLANE, Inc, together with its subsidiaries, operates as a digital marketplace for used vehicles, which connects sellers and buyers in North America, Europe, the Philippines, and Uruguay. The company operates through two segments, Marketplace and Finance. The Marketplace segment offers digital marketplace services for buying and selling used vehicles.
See Also
- Five stocks we like better than OPENLANE
- How Investors Can Find the Best Cheap Dividend Stocks
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Stock Market Sectors: What Are They and How Many Are There?
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for OPENLANE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OPENLANE and related companies with MarketBeat.com's FREE daily email newsletter.